Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4406741000168111 | 2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg / 5 mL injection, 5 x 5 mL ampoules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4406751000168113 | 2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, 5 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| 2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, 5 x 5 mL ampoules | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| 2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, 5 x 5 mL ampoules | has MPUU | 2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, ampoule | true | Inferred relationship | Some | 1102930408 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dimaval 250 mg/5 mL injection, 5 x 5 mL ampoules | Is a | True | 2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, 5 x 5 mL ampoules | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set